Lapatinib Pre-Surgical Phase II Study in Primary Breast Cancer

Trial Profile

Lapatinib Pre-Surgical Phase II Study in Primary Breast Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Feb 2016

At a glance

  • Drugs Lapatinib (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms PSL
  • Most Recent Events

    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database record, EudraCT2006-001055-35).
    • 12 Jul 2011 Status changed from completed to recruiting as reported by European Clinical Trials Database.
    • 21 Jan 2011 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top